Moreover, compared with healthy controls, TLRs-induced up-regulation of CD40, CD80, and CD86, but not MHCII was significantly decreased on B cell surface in AD-HIES patients, which suggested a defective TLRs-induced B cell activation in AD-HIES patients. This evidence concerns the gene CD86 and Alzheimer disease.